13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001053906
Total reported value
$931.1M
$931.1M
2 檔
255.8%
In Q3 2024, Artal Group S.A.'s U.S. equity holdings reached a combined market value of $931.1M, distributed across 2 disclosed stock positions.
In Q3 2024, Artal Group S.A. adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 107 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including CAVA, LXRX) accounted for 255.8% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CAVA | Cava Group Inc | Stock-Consumer Disc | 91.02% | -21.26% | -25.52% | |
| 2 | LXRX | Lexicon Pharmaceuticals Inc | Stock-Other | 8.98% | +21.26% | -22.23% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CAVA | Cava Group Inc | +35.4% | -25.52% | Trim |
| 2 | LXRX | Lexicon Pharmaceuticals Inc | +1.5% | -22.23% | Trim |
| 3 | CRBU | Caribou Biosciences Inc | — | EXIT | Sold out |
| 4 | DELL | Dell Technologies -c | — | EXIT | Sold out |
| 5 | DLO | DLocal Limited | — | EXIT | Sold out |
| 6 | ✓ | Portage Fintech Acquisitio A | — | EXIT | Sold out |
| 7 | 8QR | Confluent Inc-class A | 0% | EXIT | Sold out |
| 8 | CCC | Ccc Intelligent Solutions Ho | 0% | EXIT | Sold out |
| 9 | META | Meta Platforms Inc-class A | 0% | EXIT | Sold out |
| 10 | ADBE | Adobe Inc | 0% | EXIT | Sold out |
| 11 | INTA | Intapp Inc | 0% | EXIT | Sold out |
| 12 | TSLA | Tesla Inc | 0% | EXIT | Sold out |
| 13 | RELY | Remitly Global Inc | 0% | EXIT | Sold out |
| 14 | CYCN | Cyclerion Therapeutics Inc | 0% | EXIT | Sold out |
| 15 | EDU | New Oriental Educatio-sp Adr | 0% | EXIT | Sold out |
| 16 | BZ | Kanzhun LTD - Adr | 0% | EXIT | Sold out |
| 17 | FROG | JFrog Ltd. | 0% | EXIT | Sold out |
| 18 | INTC | Intel CORP | 0% | EXIT | Sold out |
| 19 | IRWD | Ironwood Pharmaceuticals Inc | 0% | EXIT | Sold out |
| 20 | PEGA | Pegasystems Inc | 0% | EXIT | Sold out |
| 21 | SNOW | Snowflake Inc | 0% | EXIT | Sold out |
| 22 | 698 | Achilles Therapeutics Pl-adr | 0% | EXIT | Sold out |
| 23 | ✓ | 0% | EXIT | Sold out | |
| 24 | GOOGL | Alphabet Inc-cl A | 0% | EXIT | Sold out |
| 25 | MGX | Metagenomi Therapeutics Inc | 0% | EXIT | Sold out |
| 26 | TRML | Tourmaline Bio Inc | 0% | EXIT | Sold out |
| 27 | RBRK | Rubrik Inc-a | 0% | EXIT | Sold out |
| 28 | KRON1USD | Kronos Bio Inc | 0% | EXIT | Sold out |
| 29 | MDB | Mongodb Inc | 0% | EXIT | Sold out |
| 30 | PANW | Palo Alto Networks Inc | 0% | EXIT | Sold out |
| 31 | KYTX | Kyverna Therapeutics Inc | 0% | EXIT | Sold out |
| 32 | QCOM | Qualcomm Inc | 0% | EXIT | Sold out |
| 33 | PCOR | Procore Technologies Inc | -0.1% | EXIT | Sold out |
| 34 | NOW | Servicenow Inc | -0.1% | EXIT | Sold out |
| 35 | OVID | Ovid Therapeutics Inc | -0.1% | EXIT | Sold out |
| 36 | 2JQ | Gritstone Bio Inc | -0.1% | EXIT | Sold out |
| 37 | PEPG | Pepgen Inc | -0.1% | EXIT | Sold out |
| 38 | KVUE | Kenvue Inc | -0.1% | EXIT | Sold out |
| 39 | SGMT | Sagimet Biosciences Inc-a | -0.1% | EXIT | Sold out |
| 40 | GLYCEUR | Glycomimetics Inc | -0.1% | EXIT | Sold out |
| 41 | PYPL | Paypal Holdings Inc | -0.1% | EXIT | Sold out |
| 42 | RGNX | Regenxbio Inc | -0.1% | EXIT | Sold out |
| 43 | OHI | Omega Healthcare Investors, Inc. | -0.1% | EXIT | Sold out |
| 44 | ✓ | Elevation Oncology Inc | -0.1% | EXIT | Sold out |
| 45 | ✓ | Adc Therapeutics SA | -0.1% | EXIT | Sold out |
| 46 | BEKE | Ke Holdings Inc-adr | -0.1% | EXIT | Sold out |
| 47 | AMZN | Amazon.com Inc | -0.1% | EXIT | Sold out |
| 48 | FATE | Fate Therapeutics Inc | -0.1% | EXIT | Sold out |
| 49 | ✓ | Hookipa Pharma | -0.1% | EXIT | Sold out |
| 50 | DDOG | Datadog Inc - Class A | -0.1% | EXIT | Sold out |
According to official SEC Form 13F filings, Artal Group S.A. reported a total U.S. public equity portfolio value of $931.1M across 2 disclosed positions in Q3 2024.
During Q3 2024, Artal Group S.A.'s top holdings by market value included CAVA (91.0%)、LXRX (9.0%). The largest single position, CAVA, represented 91.0% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top Position Liquidated / Trimmed
ARWR
前期市值: $108.9M
In Q3 2024, Artal Group S.A. made 109 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 2 holdings, and fully liquidating 107 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.